Table 1.
Protein Name | Protein Type | Glutathionylated Cysteine(s) | Direct Effect(s) on Protein | Physiological Effect(s) in ECs | Reference(s) |
---|---|---|---|---|---|
4.1. Epigenetics regulators | |||||
Histone H3 | Nucleosomal | C110 | Not confirmed | Regulation of gene expression via modulating chromatin structure | [13,14] |
Sirtuin1 | Histone deacetylase | C67 C268 C623 | Inhibition of enzymatic activity | Apoptosis - Senescence | [15,16,17] |
4.2. Transcription factors | |||||
p65 | Transcription factor | Unknown | Inhibition of nuclear translocation | Angiogenesis & cell survival | [18] |
p50 | C62 | Inhibition of DNA-binding activity | [19] | ||
c-jun | C269 | Unknown | [20,21] | ||
p53 | C124 C141 C182 | Inhibition of DNA-binding and protein dimerization | Angiogenesis & cell survival (supposed) | [22] | |
HIF-1a | C520 | Protein stabilization | Angiogenesis & ischemic revascularisation | [23,24] | |
STAT3 | C328 C542 | Inhibition of phosphorylation and activity | Anti-angiogenesis and reduced inflammation | [25,26,27,28] | |
STAT1 | C324 C492 | Protein activation | Unknown | [28] | |
Keap1 | Nrf2 inhibitor | C434 | Inhibition of Nrf2 binding | Antioxidant and anti-inflammatory response via Nrf2 signalling | [29,30] |
IKKb | Kinase | C179 | Inhibition of kinase activity | Angiogenesis & neovascularisation | [31] |
5. Kinases & phosphatases | |||||
LMW PTP | Phosphatase | Unknown | Inhibition of activity | Cell migration and angiogenesis | [32] |
PTP1B | C215 | Not confirmed | [33,34] | ||
Rac1 | Small Rho GTPase | C81 C157 | Altered actin structure and barrier function | [35,36] | |
Rac2 | C157 | Increased GTP-binding activity | Unknown | [36,37] | |
Ras | GTPase | C118 | Not confirmed | Unknown | [36,38,39] |
PKA | Kinase | C199 | Inhibition of activity | Alteration of barrier function and blood pressure regulation (supposed) | [40,41] |
PKB | Unknown | [40,42,43] | |||
MEKK1 | C1238 | [40,44] | |||
PKC | Unknown | [40,45] | |||
6. RONS production | |||||
p47 phox | NADPH oxidase | C98 C111 C196 | Enhanced protein function | Sustained superoxide production Endothelial dysfunction (supposed) | [46] |
Complex I | NADH-ubiquinone oxidoreductase | Unknown | [47] | ||
eNOS | Oxide synthase | C689 C908 | Protein uncoupling | Sustained superoxide production Impaired vasodilation and endothelial dysfunction | [48,49,50,51,52] |
7. Calcium-dependent channels | |||||
IP3R | Ca2+ channel | Unknown (C34 C42 C65?) | Protein activation | Increased [Ca2+]i
Regulation of Ca2+ homeostasis |
[53,54,55] |
PMCA | Ca2+ ATPase pump | Unknown | Protein inhibition | [56] | |
SERCA2b | C674 | Protein activation | Increased Ca2+ uptake in ER stores Cell migration and angiogenesis |
[57,58,59,60,61,62] | |
STIM1 | Ca2+ sensor | C56 | Protein oligomerization | Increased [Ca]i via Orai1 activation Mitochondrial dysfunction | [63] |
8. Apoptosis and autophagy | |||||
Fas | Death receptor | C294 | Enhanced activity | Cell death | [64] |
Caspase-3 | Protease | C45 (p12) C135 (p17) |
Inhibition of proteolytic activity | Cell survival | [65,66] |
Caspase-8 | Unknown | [67] | |||
Beclin-1 | Autophagy-related protein | Unknown | Upregulation of protein activity | Not confirmed | [68] |
9. Cell structure and dynamics | |||||
ProMMPs | Metalloprotease | PRCGVPD motif on inhibitory domain | Activation | Angiogenesis and vascular permeability | [69] |
ICAM-1 | Adhesion receptor | Unknown | Protein degradation | Cell junction disassembly | [70] |
Actin | Cytoskeletal | C374 | Inhibition of polymerization | Inhibition of cell motility | [71,72,73] |
Microtubules | Unknown | Cell growth arrest and apoptosis | [74,75] |